Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy of Alemtuzumab in Pediatric Intestinal Transplantation
This study is ongoing, but not recruiting participants.
Study NCT01208337   Information provided by University of Pittsburgh

First Received on September 22, 2010.   Last Updated on August 5, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Evidence of Liver Transplantation
Rejection
Interventions listed in this trial
Alemtuzumab
Additional drug interventions recognized in this trial
Antibodies, Neoplasm
Campath 1G
More general drug interventions related to this trial
Antineoplastic Agents
Immunologic Factors
Immunosuppressive Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
University of Pittsburgh


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services